Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MACK

Merrimack Pharmaceuticals Inc

Dec 01 • 04:00PM ET

12.90

Dollar change +0.28
Percentage change 2.22	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.10	Insider Own	1.82%	Shs Outstand	14.21M	Perf Week	0.23%
Market Cap	184.73M	Forward P/E	-	EPS next Y	-	Insider Trans	115.04%	Shs Float	14.06M	Perf Month	4.88%
Income	-1.43M	PEG	-	EPS next Q	-	Inst Own	60.75%	Short Float / Ratio	6.55% / 27.70	Perf Quarter	5.39%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-0.57%	Short Interest	0.92M	Perf Half Y	2.26%
Book/sh	1.31	P/B	9.82	EPS next Y	-	ROA	-8.70%	Target Price	4.00	Perf Year	8.31%
Cash/sh	1.32	P/C	9.77	EPS next 5Y	5.60%	ROE	-8.96%	52W Range	10.10 - 13.15	Perf YTD	12.57%
Dividend	-	P/FCF	-	EPS past 5Y	58.95%	ROI	-7.62%	52W High	-1.90%	Beta	1.57
Dividend %	-	Quick Ratio	39.14	Sales past 5Y	0.00%	Gross Margin	-	52W Low	27.72%	ATR	0.20
Employees	-	Current Ratio	39.14	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	62.45	Volatility	1.62% 1.66%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	40.91%	Profit Margin	-	Rel Volume	1.21	Prev Close	12.62
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 02 AMC	Payout	-	Avg Volume	33.25K	Price	12.90
Recom	4.00	SMA20	2.45%	SMA50	3.93%	SMA200	5.46%	Volume	40,207	Change	2.22%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-07-16	Downgrade	JP Morgan	Overweight → Neutral
May-27-16	Initiated	Robert W. Baird	Neutral	$8
Dec-23-15	Reiterated	Mizuho	Buy	$16 → $13
Oct-27-15	Reiterated	Oppenheimer	Outperform	$13 → $15
Apr-21-15	Reiterated	Mizuho	Buy	$13 → $16
Oct-10-14	Resumed	Oppenheimer	Outperform	$9 → $11
Jul-08-14	Resumed	Brean Capital	Buy	$16
Jun-20-14	Reiterated	Oppenheimer	Outperform	$10 → $8.50
Aug-09-13	Reiterated	Oppenheimer	Outperform	$12 → $10
Jun-25-13	Initiated	Mizuho	Buy	$12
May-08-12	Initiated	Oppenheimer	Outperform	$12

Show Previous Ratings

Nov-02-23 04:30PM	Merrimack Reports Third Quarter 2023 Financial Results (Business Wire)
Aug-15-23 07:02AM	Western Standard LLC Boosts Stake in Merrimack Pharmaceuticals Inc (GuruFocus.com)
Aug-03-23 04:30PM	Merrimack Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-03-23 08:24AM	Companies Like Merrimack Pharmaceuticals (NASDAQ:MACK) Can Afford To Invest In Growth (Simply Wall St.)
May-04-23 05:00PM	Merrimack Reports First Quarter 2023 Financial Results (Business Wire)
07:02AM	Loading…
Apr-19-23 07:02AM	Retail investors account for 38% of Merrimack Pharmaceuticals, Inc.'s (NASDAQ:MACK) ownership, while hedge funds account for 33% (Simply Wall St.)
Mar-09-23 04:40PM	Merrimack Reports Full Year 2022 Financial Results (Business Wire)
Jan-23-23 08:44AM	Merrimack Pharmaceuticals (NASDAQ:MACK) Is In A Strong Position To Grow Its Business (Simply Wall St.)
Dec-28-22 10:15PM	12 Best Performing Biotech Stocks in 2022 (Insider Monkey)
Dec-13-22 06:44AM	Bullish Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) insiders filled their treasuries with US$574k worth of stock over last year (Simply Wall St.)
Dec-05-22 09:00AM	Merrimack Pharmaceuticals Extends Section 382 Net Operating Loss Rights Plan (Business Wire)
Nov-17-22 06:56AM	The Zacks Analyst Blog Highlights Merrimack Pharmaceuticals, Moderna and Seagen (Zacks)
Nov-16-22 11:28AM	Biotech Stock Roundup: MACK Up on Study Data, MRNA Offers Vaccine Update & More (Zacks)
Nov-10-22 05:11AM	Hedge funds investors control 44% of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) and were rewarded last week after stock increased 228% (Simply Wall St.)
Nov-09-22 10:13AM	Merrimack stock rockets 200% after positive trial data on Onivyde pancreatic cancer treatment (MarketWatch) +212.75%
09:04AM	Loading…
09:04AM	Why Merrimack Shares Are Surging Over 200% Today? (Benzinga)
Nov-03-22 04:45PM	Merrimack Reports Third Quarter 2022 Financial Results (Business Wire)
Aug-16-22 08:11AM	Companies Like Merrimack Pharmaceuticals (NASDAQ:MACK) Are In A Position To Invest In Growth (Simply Wall St.)
Aug-04-22 05:00PM	Merrimack Reports Second Quarter 2022 Financial Results (Business Wire)
Aug-03-22 11:49AM	Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure (Benzinga) -14.46%
08:30AM	Merrimack Provides Ipsen Report of Results From Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung Cancer (Business Wire)
Jul-06-22 07:07AM	Bullish insiders at Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) loaded up on US$574k of stock earlier this year (Simply Wall St.)
May-05-22 04:30PM	Merrimack Reports First Quarter 2022 Financial Results (Business Wire)
Mar-09-22 04:30PM	Merrimack Reports Full Year 2021 Financial Results (Business Wire) +5.49%
Jan-27-22 04:48AM	Insider Buying: The Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Co-Founder & Independent Director Just Bought 63% More Shares (Simply Wall St.) -5.34%
Dec-06-21 07:22AM	Here's Why We're Not At All Concerned With Merrimack Pharmaceuticals' (NASDAQ:MACK) Cash Burn Situation (Simply Wall St.)
Nov-04-21 05:00PM	Merrimack Reports Third Quarter 2021 Financial Results (Business Wire)
Sep-06-21 09:50AM	A Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) insider increased their holdings by 43% last year (Simply Wall St.)
Aug-05-21 04:30PM	Merrimack Reports Second Quarter 2021 Financial Results (Business Wire)
Jun-08-21 05:31AM	Companies Like Merrimack Pharmaceuticals (NASDAQ:MACK) Can Afford To Invest In Growth (Simply Wall St.)
02:10PM	Loading…
Jun-07-21 02:10PM	Elevation Oncology Files for $100M IPO (Benzinga)
May-28-21 08:00AM	180 Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA and Teresa DeLuca MD, MBA to Board of Directors (GlobeNewswire)
Mar-10-21 06:00PM	Merrimack Reports Full Year 2020 Financial Results (Business Wire)
Dec-10-20 02:10AM	How Much Of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Do Institutions Own? (Simply Wall St.)
Dec-03-20 07:46AM	The Daily Biotech Pulse: Lilly Secures Additional Orders For COVID-19 Antibody Treatment, Decision Day For BioCryst, Kinnate Biopharma To Make Wall Street Debut (Benzinga) -6.01%
Nov-29-20 12:12PM	Where Do Hedge Funds Stand On Merrimack Pharmaceuticals Inc (MACK)? (Insider Monkey)
Nov-05-20 08:20AM	Merrimack Reports Third Quarter 2020 Financial Results (Business Wire)
Aug-07-20 08:20AM	Merrimack Reports Second Quarter 2020 Financial Results (Business Wire)
Aug-05-20 08:33AM	We Think Merrimack Pharmaceuticals (NASDAQ:MACK) Needs To Drive Business Growth Carefully (Simply Wall St.)
May-07-20 06:10PM	Merrimack Reports First Quarter 2020 Financial Results (Business Wire)
Apr-02-20 08:30AM	Merrimack Divests Early Stage Asset for $2.25 Million; Provides Strategy Update (Business Wire) +8.60%
Feb-07-20 11:14AM	What Kind Of Share Price Volatility Should You Expect For Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK)? (Simply Wall St.)
Dec-22-19 07:44PM	Hedge Funds Are Selling Merrimack Pharmaceuticals Inc (MACK) (Insider Monkey)
Dec-03-19 09:15AM	Merrimack Pharmaceuticals Adopts Section 382 Net Operating Loss Rights Plan (Business Wire) +9.87%
08:45AM	Merrimack Receives $5 Million Milestone Payment from Ipsen; Declares $6.7 Million Special Dividend (Business Wire)
Oct-28-19 06:04AM	Proxy fights reach 'frightening' level in life sciences, other industries, top attorney says (American City Business Journals)
Sep-24-19 04:45PM	JFL Capital Ends Campaign at Merrimack (PR Newswire)
Sep-19-19 03:23PM	Should You Buy Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) For This Reason? (Simply Wall St.)
09:00AM	Merrimack Pharmaceuticals Announces Changes to Board of Directors (Business Wire)
Aug-26-19 11:27AM	Texas investor group fighting for control of crumbling Merrimack Pharmaceuticals (American City Business Journals)
09:00AM	Merrimack Pharmaceuticals Issues Letter to Shareholders (Business Wire)
Aug-22-19 08:30AM	JFL Capital Issues Letter to Fellow Merrimack Stockholders (PR Newswire)
Aug-16-19 09:15AM	Merrimack Pharmaceuticals Reschedules 2019 Annual Meeting of Shareholders for October 17, 2019 (Business Wire)
Jul-25-19 08:30AM	Merrimack Declares $20 Million Special Dividend (PR Newswire) +7.59%
May-31-19 07:34AM	The Daily Biotech Pulse: Merrimack To Stay Independent, Chinese Cheer For Beigene, XBiotech Offering (Benzinga) -6.09%
06:21AM	Merrimack axes remaining staff, execs after selling assets to New York startup (American City Business Journals)
May-30-19 04:05PM	Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Special Cash Dividend (PR Newswire)
May-10-19 07:30AM	Merrimack Reports First Quarter 2019 Financial Results (PR Newswire)
May-06-19 01:46PM	COMM 2014-UBS2 Mortgage Trust -- Moody's affirms ten classes of COMM 2014-UBS2 (Moody's)
May-03-19 05:43PM	COMM 2014-UBS2 Mortgage Trust -- Moody's affirms ten classes of COMM 2014-UBS2 (Moody's)
Apr-18-19 03:07PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK (GlobeNewswire)
Apr-16-19 04:15PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK (ACCESSWIRE)
Apr-12-19 01:57PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK (GlobeNewswire)
Apr-09-19 05:50PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK (PR Newswire)
Apr-08-19 10:12AM	Merrimack Pharmaceuticals, Inc. (MACK) - Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation (ACCESSWIRE)
Apr-05-19 08:29AM	The Merrimack Pharmaceuticals (NASDAQ:MACK) Share Price Is Down 92% So Some Shareholders Are Rather Upset (Simply Wall St.) -16.41%
07:48AM	The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership (Benzinga)
Apr-04-19 05:58PM	Merrimack shelves another cancer drug, plans more layoffs (American City Business Journals)
04:15PM	Merrimack Discontinues Development of MM-310 (PR Newswire)
Mar-07-19 09:06AM	Merrimack (MACK) Incurs Narrower-Than-Expected Loss in Q4 (Zacks)
Mar-06-19 07:00AM	Merrimack Reports Fourth Quarter and Full Year 2018 Financial Results (PR Newswire) +8.63%
Feb-12-19 07:35AM	New Research: Key Drivers of Growth for ON Semiconductor, Entegris, Universal, MarineMax, Epizyme, and Merrimack Pharmaceuticals Factors of Influence, Major Initiatives and Sustained Production (GlobeNewswire)
Feb-11-19 09:39AM	Merrimack (MACK) Stock Up Year to Date: Is a Rebound Likely? (Zacks)
Jan-28-19 10:19PM	Edited Transcript of MACK earnings conference call or presentation 7-Nov-18 1:30pm GMT (Thomson Reuters StreetEvents)
Dec-10-18 05:00PM	John M. Dineen Appointed to Syneos Health Board of Directors, Named Chairman (GlobeNewswire)
Nov-09-18 10:31AM	Merrimack (MACK) Suffers Wider-Than-Expected Loss in Q3 (Zacks)
08:45AM	Research Report Identifies Merrimack Pharmaceuticals, PNM Resources, Inc. (Holding Co.), Carrols Restaurant Group, American Axle & Manufacturing, CBIZ, and Nova Measuring Instruments with Renewed Outlook Fundamental Analysis, Calculating Forward Movement (GlobeNewswire)
Nov-08-18 10:17AM	Merrimack to shelve lead cancer drug, lay off most of workforce (American City Business Journals)
Nov-07-18 06:45AM	Merrimack Reports Third Quarter 2018 Financial Results and Provides Strategic Update Following Portfolio Review (PR Newswire) +9.20%
Nov-06-18 01:44PM	Merrimack Pharmaceuticals Q3 Earnings Preview (Benzinga)
Nov-05-18 07:55AM	5 Drug/Biotech Stocks Set to Trump Estimates in Q3 Earnings (Zacks)
Oct-31-18 04:05PM	Merrimack Announces Timing of Third Quarter 2018 Investor Conference Call (PR Newswire)
Oct-24-18 11:19AM	Biotech Stock Roundup: BIIB Tops, MACK Plunges, REGN's Asthma Drug Gets FDA Nod (Zacks) -6.67%
Oct-19-18 10:48AM	Merrimack's String of Failures Continues With Lung Cancer Study Shelved After Midstage Trials (Benzinga) -22.29%
07:46AM	Merrimack Pharmaceuticals' stock plummets toward record low after cancer drug trial terminated (MarketWatch)
06:00AM	Merrimack Discontinues Phase 2 SHERLOC Study of MM-121 in Patients with Non-Small Cell Lung Cancer Due to Futility (PR Newswire)
Oct-16-18 07:30AM	Detailed Research: Economic Perspectives on Clearside Biomedical, JELD-WEN Holding, L.B. Foster, Merrimack Pharmaceuticals, Everi, and Drive Shack What Drives Growth in Today's Competitive Landscape (GlobeNewswire)
Oct-11-18 05:16PM	Merrimack (MACK) Focuses on Early Stage Pipeline and Cost Cuts (Zacks)
Sep-20-18 07:00AM	Merrimack Receives $5 Million Milestone Payment from Shire (PR Newswire)
Sep-06-18 10:35AM	Merrimack (MACK) Up 6.7% Since Last Earnings Report: Can It Continue? (Zacks) -5.75%
06:50AM	Merrimack Completes Enrollment in Randomized Phase 2 SHERLOC Study of MM-121 (seribantumab) in Non-Small Cell Lung Cancer (NSCLC) (PR Newswire)
Sep-05-18 12:06PM	Edited Transcript of MACK earnings conference call or presentation 7-Aug-18 12:30pm GMT (Thomson Reuters StreetEvents)
Sep-04-18 10:07AM	Zacks.com highlights: American Woodmark, Adverum Biotechnologies, Merrimack Pharmaceuticals, Athene Holding and M&T Bank (Zacks)
Aug-16-18 08:00AM	Factors of Influence in 2018, Key Indicators and Opportunity within Celsion, Alpha and Omega Semiconductor, SP Plus, Merrimack Pharmaceuticals, La Jolla Pharmaceutical, and SPX New Research Emphasizes Economic Growth (GlobeNewswire)
Aug-08-18 10:20AM	Merrimack (MACK) Suffers Wider-Than-Expected Loss in Q2 (Zacks)
Aug-07-18 08:18AM	Merrimack (MACK) Reports Wider-than-Expected Q2 Loss (Zacks)
06:30AM	Merrimack Reports Second Quarter 2018 Financial Results (PR Newswire)
06:30AM	Merrimack Pharmaceuticals, Inc. to Host Earnings Call (ACCESSWIRE)
Aug-01-18 12:09PM	Is a Beat in the Cards for Merrimack (MACK) in Q2 Earnings? (Zacks)
Jul-31-18 04:10PM	Merrimack Announces Timing of Second Quarter 2018 Investor Conference Call (PR Newswire)

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Andersen Eric	Director	Nov 17	Buy	12.50	300	3,750	1,659,216	Nov 20 06:59 PM
Andersen Eric	Director	Nov 14	Buy	12.50	50,170	627,125	1,658,981	Nov 16 05:09 PM
Andersen Eric	Director	Nov 09	Buy	12.19	9,975	121,618	1,577,704	Nov 13 04:05 PM
Andersen Eric	Director	Nov 08	Buy	12.13	13,823	167,701	1,569,894	Nov 13 04:05 PM
CROCKER GARY L	See Remarks	Aug 11	Buy	12.43	2,000	24,865	133,105	Aug 14 04:06 PM
CROCKER GARY L	See Remarks	Aug 10	Buy	12.52	2,000	25,039	133,105	Aug 14 04:06 PM
Andersen Eric	Director	Aug 08	Buy	12.00	87,057	1,044,327	1,565,111	Aug 09 04:06 PM
Andersen Eric	Director	Aug 07	Buy	12.00	134,493	1,614,414	1,496,680	Aug 09 04:06 PM
Andersen Eric	Director	Mar 21	Buy	11.52	160,590	1,849,997	1,412,044	Mar 22 04:06 PM
Andersen Eric	Director	Jan 31	Buy	11.40	2,232	25,444	1,284,635	Feb 01 04:05 PM
Andersen Eric	Director	Jan 30	Buy	11.36	24,708	280,624	1,282,853	Feb 01 04:05 PM
Andersen Eric	Director	Jan 27	Buy	11.40	21,875	249,298	1,263,103	Jan 31 04:05 PM
Levy Noah G.	Director	Jan 12	Buy	11.90	100,000	1,190,000	1,119,586	Jan 17 04:05 PM
Radeljevic Ana	Director	Jan 06	Buy	12.03	4,156	49,997	4,156	Jan 09 04:06 PM
Levy Noah G.	Director	Jan 03	Buy	11.24	5,300	59,564	1,019,586	Jan 04 04:06 PM
Andersen Eric	Director	Dec 30	Buy	11.33	41,300	468,041	1,223,225	Jan 03 04:16 PM
Levy Noah G.	Director	Dec 30	Buy	11.24	1,300	14,615	1,014,286	Jan 04 04:06 PM
Andersen Eric	Director	Dec 29	Buy	10.55	218,636	2,306,675	1,190,195	Jan 03 04:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MACK

Merrimack Pharmaceuticals Inc

Upgrade your FINVIZ experience